Stock Spotlight Archives - Page 53 of 383

FridaySep 08, 2023 11:25 am

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Eyes Promising Start to Expected ‘Highly Lucrative’ First Year of Gold Mining

GEMXX (OTC: GEMZ), a mine-to-market global jewelry producer, is ramping up its capacity for gold ore processing at one of its Canadian assets, enthusiastic over the better-than-expected amount of ore produced from stockpiled surface material. “GEMXX’s Snow Creek Mine property in British Columbia completed site preparation for gold processing last year and mobilized equipment in May to begin bringing the property into full production. GEMXX reported the first production of gold from the site on Aug. 15 as ore collected from a 4,500-cubic-yard sample during construction of the facility was ‘cleaned out.’ The operation yielded 38.73 ounces of gold, amounting…

FridaySep 08, 2023 11:09 am

QualityStocksNewsBreaks – GolfLync Inc.’s User-Friendly and Feature-Rich Platform Driving Exceptional Growth, Engagement

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, is soaring due to its unique and feature-strong ability to bring together people who love golf, a sport that is experiencing a post-pandemic revival. “The app (available as a free download on the Apple App Store and the Google Play Store) is powered by an intelligent algorithm that brings golfers together based upon a balanced range of factors, including handicap, preferred playing style, and location, along with various related interests and specifications. The app readily supports everything from matching individual partners to building…

WednesdaySep 06, 2023 3:18 pm

QualityStocksNewsBreaks – Why RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, available by prescription for the treatment of acquired blepharoptosis (low-lying eyelid(s)) in adults. “UPNEEQ(R) (‘RVL-1201’) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis. The company received FDA approval in July 2020 and launched UPNEEQ(R) in September 2020 to a limited number of eye care professionals, with commercial operations expanded in 2021 among ophthalmology, optometry and oculoplastic specialties,” a recent article reads. “In February 2022, UPNEEQ(R) was launched into the medical…

FridaySep 01, 2023 3:45 pm

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) Looking to Improve North America’s Graphite Infrastructure Efficiencies to Meet Surging Demand

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) is advancing its flagship Ruby Graphite Project in Beaverhead County in southwestern Montana. “With its ‘mine-to-market’ strategy, Reflex aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications… Preliminary results from the TDEM and magnetic survey have demonstrated promising anomalies, indicating the presence of conductive structures, several new anomalies, and potential graphite mineral deposits within the Ruby Graphite property. The survey data will be integrated with existing…

FridaySep 01, 2023 2:43 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs

BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently received coverage in analysis by Aegis Capital Corp. The report, which reiterated a buy recommendation and $70 target price for BVXV, contained analysis highlighting a deal valued at approximately $2.4 billion for Eli Lilly and Company’s (NYSE: LLY) acquisition of DICE Therapeutics Inc. (NASDAQ: DICE), a biopharmaceutical company that develops oral therapeutic candidates – such as DC-806 and DC-853, both oral interleukin-17 (“IL-17”) inhibitors – currently in…

FridaySep 01, 2023 1:09 pm

QualityStocksNewsBreaks – Why Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Is ‘One to Watch’

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation, and development company focusing on conventional oil and gas reservoirs in Western Canada, uses its experience to develop, acquire and drill assets with potential for primary and secondary recovery. “Prospera’s core properties include more than 42,000 cumulative acres across Cuthbert, Luseland and Heart Hills in Saskatchewan and Red Earth and Pouce Coupe in Alberta. In total, the company estimates that there are half a billion barrels of oil in place at these sites accounting for 20+ years of forward project lifespan, with as little as 8%…

FridaySep 01, 2023 12:55 pm

QualityStocksNewsBreaks – GolfLync Inc.’s Pebble Beach Sweepstakes Provides Once-in-a-Lifetime Opportunity for Golf Enthusiasts

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, previously announced the launch of the GolfLync Pebble Beach Sweepstakes. “This exciting sweepstakes gives golf enthusiasts a chance to win a dream golf trip to the iconic Pebble Beach Resorts, renowned as the No. 1 Golf Resort in America… As the greatest public golf course in America, as rated by Golf Digest, Pebble Beach has a rich history of hosting prestigious tournaments, including the U.S. Open and, for the first time in 2023, the U.S. Women’s Open. This sweepstakes provides a once-in-a-lifetime opportunity…

FridaySep 01, 2023 12:09 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Patent Protection in ‘Some of the Most Important Markets in the World’

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently received a patent from the China National Intellectual Property Administration. “The granted patent broadly covers the use of the company’s drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers. The REQORSA gene therapy in combination with Keytruda is the subject of the company’s ongoing Acclaim-2 clinical trial for the treatment of non-small cell lung cancer (‘NSCLC’). In this trial, the company is enrolling and treating patients with advanced, metastatic NSCLC whose disease progressed…

ThursdayAug 31, 2023 2:47 pm

QualityStocksNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Helping Implement Solutions Across Changing Financial Landscape

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a company formed to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. “With digital money replacing physical cash, consumers buy products and services from anywhere in the world, making payments across borders. FEXD plans to offer a diverse portfolio of products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe, and Latin America – using a growth strategy that includes developing mobile transaction platforms, applications and services to help implement the changing financial…

ThursdayAug 31, 2023 1:58 pm

QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc.’s (XESP) Unique Digital Engagement Engine(TM) Creates CX Edge

Electronic Servitor Publication Network (OTC: XESP), a market disruptor for B2B companies using cutting-edge technology to reach target markets, has developed and is commercializing its Digital Engagement Engine(TM). The solution combines automation, unique data management and microservices architecture to elevate digital content and drive better digital interactions within current and new communities. “The company anchored the development of the Digital Engagement Engine(TM) in data analysis and smart technology, creating a tech stack that can identify even the narrowest of niches within clients’ respective target markets, tailor content to meet their exact needs, and deliver the content to them right when…

Site Search

Company Search

Category: Stock Spotlight